Compare NEM & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEM | ELV |
|---|---|---|
| Founded | 1916 | 1944 |
| Country | United States | United States |
| Employees | 17500 | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9B | 85.7B |
| IPO Year | N/A | 2001 |
| Metric | NEM | ELV |
|---|---|---|
| Price | $97.53 | $394.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 19 |
| Target Price | $122.08 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 7.9M | 1.6M |
| Earning Date | 04-23-2026 | 04-22-2026 |
| Dividend Yield | 0.97% | ★ 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 8.00 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | $28.85 | N/A |
| Revenue Next Year | $5.24 | $3.07 |
| P/E Ratio | ★ $19.39 | $49.35 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $55.37 | $273.71 |
| 52 Week High | $134.88 | $426.98 |
| Indicator | NEM | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 40.17 | 51.37 |
| Support Level | $94.68 | $384.30 |
| Resistance Level | $98.58 | $408.00 |
| Average True Range (ATR) | 3.93 | 10.34 |
| MACD | 0.07 | -3.43 |
| Stochastic Oscillator | 27.23 | 20.01 |
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 11 mines and interests in two joint ventures in the Americas, Africa, Australia, and Papua New Guinea. The company is expected to sell roughly 5.3 million ounces of gold in 2026 from its continuing mines after selling six higher-cost, smaller mines following the Newcrest acquisition. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves, along with significant byproduct reserves at the end of December 2025.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.